TPOXX — a smallpox treatment that's become a backstop for patients who test positive for monkeypox in the U.S. — is going into a Phase 3 clinical trial to test its effectiveness.
, enrolling more than 500 people who test positive for monkeypox, including high-risk individuals and pregnant people.The majority of patients treated with tecovirimat recovered without symptoms by the time of their last assessment with a provider.
The bottom line:France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Trey Gowdy says Queen Elizabeth II was a 'friend to the United States'Trey Gowdy praised the remarkable life of Queen Elizabeth II following the news of her death on Thursday during his monologue on 'Sunday Night in America.'
Lire la suite »
Faculty, students sue Christian school over LGBTQ hiring banDivisions over LGBTQ-related policies have flared recently at several religious colleges in the United States
Lire la suite »
Chris Pettit settled lawsuits for Latino clients, but they say they never received all their moneyChris Pettit’s forgotten clients: He settled lawsuits for Latino clients who didn’t get their money
Lire la suite »
Which states have the lowest COVID-19 vaccination rates?CDC data shows which states have the lowest COVID-19 vaccination rates and what can be expected as the United States heads into the fall and winter.
Lire la suite »
Hellofresh: working closely with U.S. regulator after public health alertHellofresh is working closely with the United States Department of Agriculture (USDA) and one of its suppliers following a public health alert, the company said on Monday, describing the measure as 'purely precautionary'. The USDA notification affects a very small percentage of customers in the United States who had received ground beef in a certain quantity from a certain supplier, the company added.
Lire la suite »